Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Van Kessel, NL
Cornelis Petrus Maria Van Kessel, Ex Bunnik NL
| Patent application number | Description | Published |
|---|---|---|
| 20080242605 | CHEMOTAXIS-INHIBITING PROTEIN OF STAPHYLOCOCCUS (CHIPS) AND ITS USE - The present invention relates to a new protein of the bacteria | 10-02-2008 |
Cornelis Petrus Maria Van Kessel, Bunnik NL
| Patent application number | Description | Published |
|---|---|---|
| 20090202437 | Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases - The invention relates to nucleic acid molecules encoding (poly)peptides having LPI (Lectin Pathway Inhibitor) activity, to recombinant vectors harboring such molecules, and the host cells carrying the vectors. The invention further relates to methods for preparing recombinant (poly)peptides having LPI activity and to the use of such recombinant (poly)peptides having LPI activity for diagnosis, prophylaxis and treatment, such as the treatment of inflammation reactions. In addition the invention provides therapeutic and diagnostic compositions comprising as the active ingredient the (poly)peptide having LPI activity. | 08-13-2009 |
| 20090264359 | FPLR-1 INHIBITORS FOR USE IN DISEASES INVOLVING AMYLOID-INDUCED INFLAMMATORY EVENTS (FLIPR AND FLIPR-LIKE) AND IMMUNECOMPLEX-MEDIATED DISEASES - The present invention relates to a FPLR-1 inhibitor selected from the group consisting of FLIPr having the amino acid sequence MKKNITKTIIASTVIAAGLLTQTN | 10-22-2009 |
| 20100104603 | USE OF STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN 5 (SSL5) IN MEDICINE - The present invention relates to Staphylococcal superantigen-like protein 5 (SSL5) or homologues or derivatives thereof for use in medicine, in particular for use in the treatment of indications involving an excessive recruitment of leukocytes, such as stroke, perfusion/ischemia, transplant rejection, rheumatoid arthritis. The invention further relates to a pharmaceutical composition comprising SSL5 and a suitable excipient. The invention also provides the use of SSL5 for the preparation of a medicament for treatment of indications involving an excessive recruitment of leukocytes to a site of tissue damage, such as stroke, reperfusion/ischemic, transplant rejection and rheumatoid arthritis. | 04-29-2010 |
| 20110118194 | Therapeutic Use of LPI, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory Diseases - The invention relates to nucleic acid molecules encoding (poly)peptides having LPI (Lectin Pathway Inhibitor) activity, to recombinant vectors harboring such molecules, and the host cells carrying the vectors. The invention further relates to methods for preparing recombinant (poly)peptides having LPI activity and to the use of such recombinant (poly)peptides having LPI activity for diagnosis, prophylaxis and treatment, such as the treatment of inflammation reactions. In addition the invention provides therapeutic and diagnostic compositions comprising as the active ingredient the (poly)peptide having LPI activity. | 05-19-2011 |
Cornelis P.m. Van Kessel, Bunnik NL
| Patent application number | Description | Published |
|---|---|---|
| 20100298539 | NOVEL POLYPEPTIDES AND USE THEREOF - The present invention provides a polypeptide having a biological activity of the Chemotaxis Inhibitory Protein of | 11-25-2010 |
Cornelis P. M. Van Kessel, Bunnik NL
| Patent application number | Description | Published |
|---|---|---|
| 20090246175 | THERAPEUTIC USE OF SCIN, A STAPHYLOCOCCAL COMPLEMENT INHIBITOR IN INFLAMMATORY DISEASES - The present invention relates to the use of the staphylococcal complement inhibitor (SCIN) or a homologue thereof, or a derivative or a fragment of SCIN or the SCIN homologue for the preparation of a medicament for intervening with C3 and C5 convertases. The medicament is in particular intended for inhibiting activation of the classical and/or the alternative pathway of complement. More in particular, the medicament is for treating indications that involve complement activation via the classical and/or alternative pathway. | 10-01-2009 |
Gerardus Martinus Maria Van Kessel, Amsterdam NL
| Patent application number | Description | Published |
|---|---|---|
| 20110108762 | PROCESS FOR THE PRODUCTION OF ALKYLENE CARBONATE - The invention relates to a process for the production of an alkylene carbonate by the reaction of an alkylene oxide with carbon dioxide in the presence of a phosphonium catalyst in which process (a) the alkylene oxide, carbon dioxide and phosphonium catalyst are continuously introduced into a reaction zone from which a product stream containing alkylene carbonate and phosphonium catalyst is withdrawn; (b) alkylene carbonate and a stream containing phosphoniura catalyst are separated from the product stream; (c) the alkylene carbonate, separated in step (b), is recovered as product; and (d) the stream containing phosphoniura catalyst, separated in step (b), is recycled to the reaction zone, in which process a treatment of alkylene carbonate and/or catalyst with a sorption agent comprising carbon is carried out. | 05-12-2011 |
Kok P.m. Van Kessel, Ex Bunnik NL
| Patent application number | Description | Published |
|---|---|---|
| 20080233137 | Compounds that Block the C5a Receptor and Their Use in Therapy - The present invention relates to compounds that are able to prevent intramolecular contact of the N-terminal residues 10 to 18 of human C5aR with the extracellular loops thereof. More specifically the invention relates to compounds that are able to bind the aspartates in positions 10, 15 and 18 and the glycine in position 12 of the human C5aR. Such compounds are preferably of the general formula X | 09-25-2008 |
Matthijs Van Kessel, Van Kessel NL
| Patent application number | Description | Published |
|---|---|---|
| 20120035339 | ETHYLENE COPOLYMER - The invention is directed to a slurry phase polymerisation process for the preparation of ethylene-α-olefin copolymers by polymerising ethylene in the presence of a chromium containing catalyst and a diluent. The polymerisation takes place in the presence of·a chromium-containing catalyst, ·an aliphatic or alicyclic boron compound having at least one boron to carbon linkage and·an aliphatic or alicyclic group MA or group IMA element based compound having at least one metal or metalloid to carbon linkage wherein the chromium containing catalyst is not reduced by carbon monoxide after the activation in a non-reducting atmosphere and wherein the metal or metalloid is present in an amount higher than 1 ppm relative to the amount of diluent. | 02-09-2012 |
Petrus Henricus Maria Van Kessel, Tilburg NL
| Patent application number | Description | Published |
|---|---|---|
| 20100029885 | CROSSLINKED POLYMER SHEETS AND METHODS FOR MAKING SUCH - The invention relates to sheet materials comprising crosslinked polymer based layers and production methods thereof. More particularly the invention relates to gelatin based layers that are hardened by an amine-amine crosslinking compound such as triazine type crosslinking compounds. Gelatins solutions used for such materials are buffered to control the hardening speed of the gelatin solutions. This invention also relates to applications of such hardened gelatin layers such as image recording materials but also applications such as test-substrates applicable for pharmaceutical or cosmetic industry. | 02-04-2010 |